Future US Nucleic Acid Testing Market OutlookVenture Planning GroupFebruary 14, 2012 880 Pages - SKU: VPG6827395 |
More Antisense & RNAi Technology reports by Venture Planning Group
Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ...
Analysis of Nucleic Acid Testing Instrumentation And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into ...
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings ...
Analysis of the World Nucleic Acid Testing Market Sales Forecasts by Country and Strategic Profiles of Leading Suppliers by Venture Planning Group
See all reports like this >>This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well ...
More United States Antisense & RNAi Technology reports
Future Horizons in the US Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment by Venture Planning Group
Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as ...
2012 US Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
Highlights
Comprehensive 880-page market segmentation analysis of the US NAT market.
Major issues pertaining to the ...
Opportunities in Stem Cell Technology by Kalorama Information
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem ...
The U.S. Market and Developments Associated with Psoriasis by Kalorama Information
See all reports like this >>Psoriasis has long been a dermatological problem that affects millions of people in the US. Current therapeutic approaches such as lubricants, keratolytic agents and topical ...
More United States reports
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
See all reports like this >>D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Antisense & RNAi Technology Reports
- Antisense Therapeutics Limited – Product Pipeline Review – 2013
- RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013
- MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
- RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2012
- Strategies and Technologies for Target Validation
